triumph-1 trial retatrutide 🚨 BREAKING: Shows “Bariatric-Level” Weight Loss in Phase 3 New Phase 3 data show retatrutide may deliver weight-loss outcomes approaching those seen with bariatric surgery—marking one of the most What Pharmacists Need to Know

5 Even modest weight loss is clinically meaningful: reductions of 5% of baseline weight can improve blood pressure, glucose levels and cardiovascular risk

Normoglycemics patients affected by asymptomatic significant carotid artery stenosis at 2 years of Follow-Up: role of microRNAs Modulation: the ATIMIR Study

The TRIUMPH-4 result of 28.7% at 68 weeks exceeded the Phase 2 result, suggesting the effect strengthens with longer treatment

Patients with Hashimoto's typically present with symptoms of hypothyroidism including fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, and cognitive difficulties such as poor concentration or memory problems